Genpact Valuation

G -- USA Stock  

Fiscal Quarter End: December 31, 2019  

Genpact Limited retains regular Real Value of $42.12 per share. The prevalent price of the corporation is $40.72. At this time the corporation appears to be fairly valued. This module calculates value of Genpact Limited from evaluating the corporation fundamentals such as Current Valuation of 8.68 B, Return On Asset of 0.0003  and Return On Equity of 0.0007  as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
Fairly Valued
November 17, 2019
40.72
Market Value
42.12
Real Value
45.69
Upside
Genpact is very steady asset. Calculation of real value of Genpact Limited is based on 3 months time horizon. Increasing Genpact Limited time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
Genpact Limited Valuation Data Drivers
Average Assets    Enterprise Value    Market Capitalization    

Genpact Market Cap

Genpact Limited is rated below average in market capitalization category among related companies. Market capitalization of Business Services industry is currently estimated at about 204.42 Billion. Genpact holds roughly 7.42 Billion in market capitalization claiming about 4% of stocks in Business Services industry.
Capitalization  Workforce  Valuation  Total debt  Revenue
Horizon     30 Days    Login   to change
Genpact Limited is rated below average in price to sales category among related companies. It is rated below average in beta category among related companies totaling about  0.34  of Beta per Price to Sales. The ratio of Price to Sales to Beta for Genpact Limited is roughly  2.91 

Valuation Basics

Genpact Enterprise Value Fundamentals

Quick Ratio1.24
Earnings Quarterly Growth19.70%
Revenue Growth18.80%
Payout Ratio21.62%
Enterprise Value To Ebitda15.91
Earnings Growth18.40%
Enterprise Value To Revenue2.51
Please also check Risk vs Return Analysis. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com